Impact BioMedical, Inc. (IBO)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	46.00M
Revenue (ttm)	n/a
Net Income (ttm)	-6.46M
Shares Out	11.50M
EPS (ttm)	-0.56
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IBO

Impact Biomedical Inc. is a subsidiary of DSS, Inc (“DSS”: NYSE). IBIO discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships. Our activities range from the discovery of technologies and leveraging those technologies to create and commercialize product candidates. Currently, our operations are conducted, and our assets are owned primarily through o...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 1
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: IBO